AI-guided AF Treatment
ConditionAtrial Fibrillation (AF)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorEast and North Hertfordshire NHS Trust
About this trial
Two-centre, prospective, randomized, open-label, controlled pilot study to examine whether integrating an artificial intelligence virtual assistant (VA), instructed with the latest international guidelines on optimal patient management into the outpatient management of patients diagnosed with atrial fibrillation (AF) in the last 6 months, is feasible, acceptable and effective in reducing the need for regular medical assessment and the healthcare burden, reduce variability, and meets with participant satisfaction, without compromising participant safety and overall care quality.
Eligibility criteria
Qualifiers
Age ≥ 18 years
Documented diagnosis of AF within the last 6 months
Patient is at least mildly symptomatic. Presence of at least one of the symptoms like palpitation, dizziness, breathlessness, pre-syncope, and syncope with at least mild intensity
Ability to understand and comprehend the study rationale, design, and process.
Disqualifiers
Severe comorbidities (such as physical impairment, cognitive impairment, and hearing loss) that could affect protocol adherence, in the opinion of the investigator
Chronic Kidney Disease (CKD) stage 4-5 or on dialysis
Medical illness with a life expectancy of less than 1 year
Alternative potentially reversible causes of AF (such as surgery, sepsis, or thyroid dysfunction)
Trial design
Treatments tested in this trial
- virtual assistant
- Standard AF care
Treatment groups
60 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov